A vs SOLV: fair value comparison
Agilent Technologies, Inc. and Solventum Corporation · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, A currently sits closer to the top of our ranking by discount to fair value. A carries the stronger quality grade.
| A | SOLV | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $170.54 | $87.29 |
| 12-month range | $110.24–$175.55 | $62.49–$92.44 |
| Rank by discount to fair value | #62 of 108 Healthcare | #63 of 108 Healthcare |
| Quality grade | B | F |
| Leverage | Moderate | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: A fair value analysis · SOLV fair value analysis